HENSIFY
LIVE

Serial Number

79219471

Owner

NANOBIOTIX

Attorney

Paul Cosmovici

Filing Date

Aug 3, 2017

Add to watchlist:

No watchlists yet
View on USPTO

HENSIFY Trademark

Serial Number: 79219471 • Registration: 5435709

HENSIFY is a trademark filed by NANOBIOTIX on August 3, 2017. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus). The application is currently registered and active.

Owner Contact Info

NANOBIOTIX (26 trademarks)

60 rue de Wattignies

Entity Type: 99

Trademark Details

Filing Date

August 3, 2017

Registration Date

April 3, 2018

Published for Opposition

January 16, 2018

Goods & Services

Pharmaceutical products, namely, agents for tumor treatment for use only in relation to radiotherapy; medicines for human use for use only in relation to radiotherapy for cancer treatment; healthcare products, namely, pharmaceutical products for cancer treatment for use only in relation to radiotherapy; drugs for medical use for cancer treatment for use only in relation to radiotherapy; preparations for medical use for use only in relation to radiotherapy, particularly for tumor treatment; radiological contrast substances for medical use; chemical reagents for medical use for use only in relation to radiotherapy for cancer treatment; medical preparations for medical or pharmaceutical use consisting of medication delivery agents in the form of tablets and capsules for cancer treatment for use only in relation to radiotherapy; chemical-pharmaceutical products consisting in tablets or injectable products for cancer treatment for use only in relation to radiotherapy; diagnostic biomarking reagents for medical use for use only in relation to radiotherapy

Diagnostic apparatus for medical use, namely, X-ray apparatus for medical use; radiology screens for medical use

Filing History

TEAS CHANGE OF CORRESPONDENCE RECEIVED
Sep 30, 2025 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Sep 30, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Sep 30, 2025 REAP
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
Nov 19, 2024 NA71
REGISTERED-SEC.71 ACCEPTED
Nov 19, 2024 71AG
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Nov 18, 2024 APRE
TEAS SECTION 71 RECEIVED
Apr 3, 2024 ES71
FINAL DECISION TRANSACTION PROCESSED BY IB
Aug 4, 2018 FINV
FINAL DISPOSITION NOTICE SENT TO IB
Jul 10, 2018 FICS
FINAL DISPOSITION PROCESSED
Jul 10, 2018 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jul 3, 2018 FICR
REGISTERED-PRINCIPAL REGISTER
Apr 3, 2018 R.PR
NOTIFICATION PROCESSED BY IB
Jan 27, 2018 GPNX
PUBLISHED FOR OPPOSITION
Jan 16, 2018 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jan 10, 2018 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Jan 10, 2018 OP2R
NOTICE OF PUBLICATION
Dec 27, 2017 NPUB
REFUSAL PROCESSED BY IB
Dec 9, 2017 RFNT
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 5, 2017 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 4, 2017 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 2, 2017 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 2, 2017 TROA
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Nov 17, 2017 RFCS
REFUSAL PROCESSED BY MPU
Nov 17, 2017 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Nov 7, 2017 RFCR
NON-FINAL ACTION WRITTEN
Nov 6, 2017 CNRT
ASSIGNED TO EXAMINER
Nov 3, 2017 DOCK
APPLICATION FILING RECEIPT MAILED
Nov 1, 2017 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 28, 2017 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Oct 26, 2017 REPR